SESN2 and urinary bladder carcinoma: More recently, Liang et al. (42) found that SESN2 was significantly decreased in human bladder cancer cells, that isorhapontigenin could upregulate SESN2 expression in a MAPK8-JUN-dependent manner, and that SESN2 induction could inhibit human bladder cancer growth by activating autophagy.